Risk for blood clots after COVID-19 vaccination explored
Mar 11, 2022
Two studies show an increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S.
Feds delay ‘ticking time bomb’ set to invalidate existing health regulations
By
Kimberly Bonvissuto
Mar 07, 2022
The federal government once again is delaying implementation of a “ticking time bomb” that threatens to invalidate thousands of existing health regulations, including protections for older adults.
Vaccination ups infection-acquired immunity against SARS-CoV-2
Mar 01, 2022
Two doses of the BNT162b2 (Pfizer-BioNTech) vaccine were linked to high short-term protection against infection, which wanes after six months.
COVID-19 vaccination tied to decline in distress in U.S. adults
Feb 24, 2022
Decreases in distress and perceived risks for infection, hospitalization and death were reported by those receiving at least one dose of the vaccine.
Low risk seen for second allergic reaction to mRNA COVID-19 vaccine
Feb 22, 2022
Of 1,366 patients with an immediate allergic reaction to the first dose, six developed a severe immediate allergic reaction after the second dose.
Bill would exempt healthcare workers from vaccination mandates
By
Kathleen Steele Gaivin
Feb 15, 2022
Healthcare workers in Tennessee who have religious objections to the COVID-19 vaccine would be exempt from vaccination mandates if Republican-led bill moves forward in the state General Assembly and is...
16-state coalition seeks to block CMS vax mandate
By
Kathleen Steele Gaivin
Feb 08, 2022
Attorneys general from 16 states asked a federal judge Friday to block the U.S. government from enforcing the Centers for Medicare & Medicaid Services’ COVID-19 vaccine mandate in their respective states...
Homologous, heterologous COVID-19 boosters are immunogenic
Feb 07, 2022
Antibody neutralizing titers against SARS-CoV-2 D614G pseudovirus increased by a factor of 4 to 73 for all combinations.
Retiring Jewish HomeLife CEO talks about the importance of succession planning, diversification and vaccine...
By
Lois A. Bowers
Feb 04, 2022
Harley Tabak (Photo courtesy of Jewish HomeLife) Harley Tabak will retire at the end of the year after two decades at the helm of Jewish HomeLife in Atlanta. In April, he’ll transition to the role of...
Risk for breakthrough SARS-CoV-2 infection lower with mRNA-1273
Feb 02, 2022
The risk for breakthrough infection and of 60-day hospitalization was significantly lower for mRNA-1273 (Moderna) versus BNT162b2 (Pfizer-BioNTech) vaccination.